|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash and Cash Equivalents at Beginning of Period | |||||
| Cash Flows from Operating Activities: | |||||
| Net Income | |||||
| Adjustments to reconcile net income to net cash provided from operating activities: | |||||
| Depreciation and amortization expense | |||||
| Deferred income tax provision (benefit) | |||||
| Stock-based compensation expense | |||||
| Unearned insurance premium | |||||
| Restructuring charges | |||||
| Payments for restructuring charges | |||||
| Loss on extinguishment of debt | |||||
| Other | |||||
| Changes in working capital: | |||||
| Receivables | |||||
| Deferred reinsurance | |||||
| Deferred customer acquisition costs | |||||
| Prepaid expenses and other current assets | |||||
| Accounts payable | |||||
| Deferred revenue | |||||
| Accrued liabilities | |||||
| Unearned insurance premium | |||||
| Current income taxes | |||||
| Net Cash Provided from Operating Activities | |||||
| Cash Flows from Investing Activities: | |||||
| Purchases of property and equipment | |||||
| Business acquisitions, net of cash acquired | |||||
| Purchases of available-for-sale securities | |||||
| Sales and maturities of available-for-sale securities | |||||
| Other investing activities | |||||
| Net Cash Provided from (Used for) Investing Activities | |||||
| Cash Flows from Financing Activities: | |||||
| Borrowings of debt, net of discount | |||||
| Repayments of debt | |||||
| Debt issuance costs paid | |||||
| Repurchases of common stock | |||||
| Other financing activities | |||||
| Net Cash Provided from (Used for) Financing Activities | |||||
| Cash Increase During the Period | |||||
| Cash and Cash Equivalents at End of Period | |||||
Loading...